BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

25 related articles for article (PubMed ID: 8131127)

  • 1. Regurgitation of my free lunch: the clinical toxicology and pharmaceutical company relationship.
    Cumpston KL
    J Med Toxicol; 2009 Dec; 5(4):257-8. PubMed ID: 20012251
    [No Abstract]   [Full Text] [Related]  

  • 2. Don't bite the hand that feeds you.
    Lexchin J
    West J Med; 1999 Oct; 171(4):238-9. PubMed ID: 10578675
    [No Abstract]   [Full Text] [Related]  

  • 3. Bioethics for clinicians: 17. Conflict of interest in research, education and patient care.
    Lemmens T; Singer PA
    CMAJ; 1998 Oct; 159(8):960-5. PubMed ID: 9834723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structured approach to pharmaceutical representatives. Family medicine residency program.
    Kelcher S; Brownoff R; Meadows LM
    Can Fam Physician; 1998 May; 44():1053-6, 1059-60. PubMed ID: 9612591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmaceutical policies in Canadian family medicine training. Survey of residency programs.
    Mahood S; Zagozeski C; Bradel T; Lawrence K
    Can Fam Physician; 1997 Nov; 43():1947-51. PubMed ID: 9386881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health sciences and the pharmaceutical industry: partnerships can be effective and ethical.
    Guyatt G
    CMAJ; 1994 Nov; 151(9):1323-5. PubMed ID: 7954183
    [No Abstract]   [Full Text] [Related]  

  • 7. [Medical ethics and the pharmaceutical industry].
    Monedero P
    Rev Esp Anestesiol Reanim; 2007 Feb; 54(2):69-72. PubMed ID: 17390687
    [No Abstract]   [Full Text] [Related]  

  • 8. To what extent do educational interventions impact medical trainees' attitudes and behaviors regarding industry-trainee and industry-physician relationships?
    Carroll AE; Vreeman RC; Buddenbaum J; Inui TS
    Pediatrics; 2007 Dec; 120(6):e1528-35. PubMed ID: 18055668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Academic medicine and the pharmaceutical industry: a cautionary tale.
    Guyatt G
    CMAJ; 1994 Mar; 150(6):951-3. PubMed ID: 8131127
    [No Abstract]   [Full Text] [Related]  

  • 10. Development of residency program guidelines for interaction with the pharmaceutical industry. Education Council, Residency Training Programme in Internal Medicine, Department of Medicine, McMaster University, Hamilton, Ont.
    CMAJ; 1993 Aug; 149(4):405-8. PubMed ID: 8348422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determining an ethical stance. Pharmaceutical industry involvement and family medicine residency training.
    Guyatt G
    Can Fam Physician; 1997 Nov; 43():1898-900, 1905-7. PubMed ID: 9386871
    [No Abstract]   [Full Text] [Related]  

  • 12. The relationship between physicians in training and pharmaceutical companies. A time for guidelines?
    Girard DE
    Arch Intern Med; 1992 May; 152(5):920-1. PubMed ID: 1580715
    [No Abstract]   [Full Text] [Related]  

  • 13. Proposed model for interaction between residents and residency training programs, and pharmaceutical industry.
    Razack S; Arbour L; Hutcheon R
    Ann R Coll Physicians Surg Can; 1999 Mar; 32(2):93-6. PubMed ID: 12378718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Of the Medical Council of India and industry freebies.
    Goel A
    Natl Med J India; 2010; 23(4):249-50. PubMed ID: 21192525
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmaceutical promotions--a free lunch?
    Waud DR
    N Engl J Med; 1992 Jul; 327(5):351-3. PubMed ID: 1620175
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.